StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.61+0.02 (+3.06%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Imunon r&d expenses

Research and development expenses are spending on new products and technology.

Imunon's R&D Expenses for the twelve months ending Mar 31, 2026 was $7.95M, down 24.3% year over year. For fiscal 2025 it was $7.78M, down 33.2% from the year before. Over ten years it grew -6.1% a year on average. The highest annual figure on record is $19.86M in fiscal 2011.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.78M-33.2%
FY2024Dec 31, 2024$11.64M+3.1%
FY2023Dec 31, 2023$11.29M-3.8%
FY2022Dec 31, 2022$11.73M+10.5%
FY2021Dec 31, 2021$10.62M-6.4%
FY2020Dec 31, 2020$11.34M-13.2%
FY2019Dec 31, 2019$13.07M+10.1%
FY2018Dec 31, 2018$11.87M-9.3%
FY2017Dec 31, 2017$13.08M-10.6%
FY2016Dec 31, 2016$14.62M-0.3%
FY2015Dec 31, 2015$14.66M-2.1%
FY2014Dec 31, 2014$14.97M+59.9%
FY2013Dec 31, 2013$9.36M-40.6%
FY2012Dec 31, 2012$15.77M-20.6%
FY2011Dec 31, 2011$19.86M+35.0%
FY2010Dec 31, 2010$14.71M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$2.34M+8.0%
Q4 FY2025Dec 31, 2025$2.49M+11.5%
Q3 FY2025Sep 30, 2025$1.90M-42.3%
Q2 FY2025Jun 30, 2025$1.23M-56.5%
Q1 FY2025Mar 31, 2025$2.17M-34.3%
Q4 FY2024Dec 31, 2024$2.23M-37.2%
Q3 FY2024Sep 30, 2024$3.29M+66.3%
Q2 FY2024Jun 30, 2024$2.82M-6.1%
Q1 FY2024Mar 31, 2024$3.29M+36.7%
Q4 FY2023Dec 31, 2023$3.55M+10.1%
Q3 FY2023Sep 30, 2023$1.98M-36.0%
Q4 FY2022Dec 31, 2022$3.00M+0.6%
Q3 FY2022Sep 30, 2022$2.41M-2.4%
Q2 FY2022Jun 30, 2022$3.23M+24.4%
Q1 FY2022Mar 31, 2022$3.10M+20.4%
Q4 FY2021Dec 31, 2021$2.99M+6.3%
Q3 FY2021Sep 30, 2021$2.47M-0.9%
Q2 FY2021Jun 30, 2021$2.59M-13.3%
Q1 FY2021Mar 31, 2021$2.57M-15.7%
Q4 FY2020Dec 31, 2020$2.81M-8.3%
Q3 FY2020Sep 30, 2020$2.49M-32.2%
Q2 FY2020Jun 30, 2020$2.99M-15.9%
Q1 FY2020Mar 31, 2020$3.05M+10.3%
Q4 FY2019Dec 31, 2019$3.07M+30.8%
Q3 FY2019Sep 30, 2019$3.67M+68.0%
Q2 FY2019Jun 30, 2019$3.56M-22.5%
Q1 FY2019Mar 31, 2019$2.77M+1.0%
Q4 FY2018Dec 31, 2018$2.34M-26.9%
Q3 FY2018Sep 30, 2018$2.19M-34.7%
Q2 FY2018Jun 30, 2018$4.59M+37.2%
Q1 FY2018Mar 31, 2018$2.74M-21.1%
Q4 FY2017Dec 31, 2017$3.21M-11.4%
Q3 FY2017Sep 30, 2017$3.35M-20.7%
Q2 FY2017Jun 30, 2017$3.35M+0.4%
Q1 FY2017Mar 31, 2017$3.48M+1.0%
Q4 FY2016Dec 31, 2016$3.62M–
Q3 FY2016Sep 30, 2016$4.23M–
Q2 FY2016Jun 30, 2016$3.34M–
Q1 FY2016Mar 31, 2016$3.44M–

More Imunon figures

See a number that looks wrong?